v3.25.0.1
Income Taxes (Tables)
 12 Months Ended
Jan. 26, 2025
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (benefit)
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Current income taxes:   
Federal$14,032 $5,710 $1,703 
State892 335 46 
Foreign699 502 228 
Total current15,623 6,547 1,977 
Deferred income taxes:
Federal(4,515)(2,499)(2,165)
State(242)(206)— 
Foreign280 216 1 
Total deferred(4,477)(2,489)(2,164)
Income tax expense (benefit)$11,146 $4,058 $(187)
Schedule of Income Before Income Tax
Income before income tax consists of the following:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
U.S.$77,456 $29,495 $3,477 
Foreign6,570 4,323 704 
Income before income tax$84,026 $33,818 $4,181 
Schedule of Effective Income Tax Rate Reconciliation
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions, except percentages)
Tax expense computed at federal statutory rate$17,645 21.0 %$7,102 21.0 %$878 21.0 %
Expense (benefit) resulting from:
State income taxes, net of federal tax effect554 0.7 %120 0.4 %50 1.2 %
Foreign-derived intangible income(2,976)(3.5)%(1,408)(4.2)%(739)(17.7)%
Stock-based compensation(2,097)(2.5)%(741)(2.2)%(309)(7.4)%
U.S. federal research and development tax credit(990)(1.2)%(431)(1.3)%(278)(6.6)%
Foreign tax rate differential(984)(1.2)%(467)(1.4)%(83)(2.0)%
Acquisition termination cost— — %— — %261 6.2 %
Other(6)— %(117)(0.3)%33 0.8 %
Income tax expense (benefit)$11,146 13.3 %$4,058 12.0 %$(187)(4.5)%
Schedule of Deferred Tax Assets and Liabilities
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below:
 Jan 26, 2025Jan 28, 2024
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure$6,256 $3,376 
GILTI deferred tax assets2,820 1,576 
Accruals and reserves, not currently deductible for tax purposes2,058 1,121 
Research and other tax credit carryforwards759 936 
Net operating loss and capital loss carryforwards456 439 
Operating lease liabilities299 263 
Stock-based compensation124 106 
Property, equipment and intangible assets82 64 
Other deferred tax assets360 179 
Gross deferred tax assets13,214 8,060 
Less valuation allowance(1,610)(1,552)
Total deferred tax assets11,604 6,508 
Deferred tax liabilities:
Unremitted earnings of foreign subsidiaries(891)(502)
Operating lease assets(286)(255)
Equity investments(264)(60)
Acquired intangibles(70)(74)
Gross deferred tax liabilities(1,511)(891)
Net deferred tax asset (1)$10,093 $5,617 
(1)    Net deferred tax asset includes long-term deferred tax assets of $11 billion and $6.1 billion and long-term deferred tax liabilities of $886 million and $462 million for fiscal years 2025 and 2024, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
Schedule of Gross Unrecognized Tax Benefits
A reconciliation of gross unrecognized tax benefits is as follows:
 Jan 26, 2025Jan 28, 2024Jan 29, 2023
 (In millions)
Balance at beginning of period$1,670 $1,238 $1,013 
Increases in tax positions for current year1,268 616 268 
Increases in tax positions for prior years48 87 1 
Decreases in tax positions for prior years(88)(148)(15)
Lapse in statute of limitations(27)(19)(20)
Settlements(10)(104)(9)
Balance at end of period$2,861 $1,670 $1,238